Wei Mingyuan M - OmicsDI

Show results for

Proteomics (2)
Metabolomics (2)
Transcriptomics (1)

Organisms

Homo sapiens (2)
Staphylococcus aureus (1)

Repository

iProX (2)
MetaboLights (2)
biostudies-arrayexpress (1)

Technology Type

Mass spectrometry (2)

Instrument Platform

Liquid Chromatography MS - alternating (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2023 (3)
2014 (1)
2024 (1)

CHEBI ID

CHEBI:10082 (2)
CHEBI:46659 (2)
CHEBI:27402 (2)
CHEBI:3746 (2)
CHEBI:3219 (2)
CHEBI:2453 (2)
CHEBI:80127 (2)
CHEBI:27836 (2)
CHEBI:27701 (2)
CHEBI:17302 (2)
CHEBI:16874 (2)
CHEBI:28919 (2)
CHEBI:6980 (2)
CHEBI:31648 (2)
CHEBI:16562 (2)
CHEBI:9093 (2)
CHEBI:16805 (2)
CHEBI:174850 (2)
CHEBI:28864 (2)
CHEBI:45980 (2)
CHEBI:8497 (2)
CHEBI:7856 (2)
CHEBI:168124 (2)
CHEBI:5856 (2)
CHEBI:5557 (2)
CHEBI:29013 (2)
CHEBI:28283 (2)
CHEBI:27870 (2)
CHEBI:3077 (2)
CHEBI:177282 (2)

Metabolite Name

Laurylaldehyde (2)
(S)-3-Hydroxyhexadecanoyl-CoA (2)
Undecan-2-one (2)
Sinensal (2)
Bupropion (2)
Ipratropium bromide (2)
Myo-inositol hexakisphosphate (2)
Haloperidol (2)
Cyanidin 3-glucoside (2)
Selenocysteine (2)
Angiotensin IV (2)
Cyclic GMP (2)
2-Methoxy-estradiol-17b 3-glucuronide (2)
Guanethidine (2)
Oxytetracycline (2)
Clindamycin phosphate (2)
Sulfinpyrazone (2)
Neryl formate (2)
Cysteic acid (2)
Prenol (2)
Beta-D-3-Ribofuranosyluric acid (2)
Xanthosine 5-triphosphate (2)
Sulindac (2)
Tobramycin (2)
Ibutilide (2)
5-Methyltetrahydrofolic acid (2)
Pentadecanal (2)
N-[(3a,5b,7a)-3-hydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]-Glycine (2)
Imidazoleacetic acid ribotide (2)
5b-Cyprinol sulfate (2)

Study type

Transcription profiling by array (1)

Release Date

2014 (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Airway Dysbiosis Accelerates Lung Function Decline in Chronic Obstructive Pulmonary Disease (Murine UPLC-MS/MS assays)

Progressive lung function decline is a hallmark of chronic obstructive pulmonary disease (COPD). Airway dysbiosis occurs in COPD, but whether it contributes to disease progression remains unknown. Here we showed, through a longitudinal analysis on two cohorts involving four UK centers, that basel...

2023-06-12 | MTBLS6894 | MetaboLights

Airway Dysbiosis Accelerates Lung Function Decline in Chronic Obstructive Pulmonary Disease (Human UPLC-MS/MS assays)

Progressive decline in lung function is a hallmark of chronic obstructive pulmonary disease (COPD). Although airway dysbiosis occurs in COPD, whether it contributes to disease progression remains unknown. Here, through a longitudinal analysis on 181 COPD individuals from two large cohorts involvi...

2023-06-12 | MTBLS5423 | MetaboLights

Phenotype and expression profile analysis of Staphylococcus aureus biofilms and planktonic cells in response to Licochalcone A

Staphylococcus aureus (S. aureus) is one of the most important pathogens in humans and animals. The formation of S. aureus biofilm is considered an important mechanism of antimicrobial resistance. Therefore, finding effective drugs against the biofilm produced by S. aureus has been a high priority. ...

ORGANISM(S): Staphylococcus aureus

2014-07-01 | E-GEOD-58938 | biostudies-arrayexpress

CCL20/CXCL5 regulates the stemness of anaplastic thyroid cancer stem cells via NF-kB pathway

The mechanism of CCL20/CXCL5 regulating anaplastic thyroid cancer cancer stem cells to promote the progression of thyroid cancer

ORGANISM(S): Homo Sapiens

2023-11-13 | PXD046889 |

Proteomic profiling reveals the impact of surface functionalization on the protein corona formed on superparamagnetic iron oxide nanoparticles

The protein corona formed on the surface of nanomaterials is critical to understanding their biological behavior, as it is regulated by both the physicochemical properties of the nanomaterials and the physiological environment. The interplay between material synthesis characteristics, protein corona...